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Sequence comparisons among methionyl-tRNA synthetases from different organisms reveal only one block of homology beyond the last B strand 
of the mononucleotide fold. We have introduced a series of semi-conservative amino acid replacements in the conserved motif of yeast methionyl- 
tRNA synthetase. The results indicate that replacements of two polar residues (Asns8’ and Arg’=) affected specifically the aminoacylation reaction. 
The location of these residues in the tertiary structure of the enzyme is compatible with a direct interaction of the amino acid side-chains with the 
tRNA anticodon. 
Methionyl-tRNA synthetase; Site-directed mutagenesis; Anticodon binding region 
1. INTRODUCTION 
The structure of a fully active fragment of the E. coli 
methionyl-tRNA synthetase (MetRS) complexed with 
ATP has recently been resolved at high resolution [I], 
but information about the regions that participate in the 
complex with the tRNA has only been generated by 
genetic and chemical cross-linking experiments. The ter- 
minal adenosine of tRNA”” is proximal to residues 
Lys”’ and LYS~~’ when bound to the synthetase [2] and 
peptide region 528-533 has been proposed to play a role 
in guiding the acceptor stem in the active site [3]. The 
interaction with the anticodon bases which specify met- 
hionine acceptance in the tRNA [4] is restricted to resi- 
dues 451467 [5-71. This region is characterised by the 
presence of a tryptophane residue (Trp46’) which is con- 
served in all methionyl-tRNA synthetases with the ex- 
ception of the yeast cytoplasmic enzyme, and has been 
shown to interact positively with methionine anticodons 
and negatively with non-methionine anticodons [6,7]. 
Recently, a structural model of the E. coli tRNAMC’- 
MetRS complex has been suggested based on structural 
similarities between methionyl- and the tRNA bound E. 
coii glutaminyl-tRNA synthetase [B]. In this model, the 
positioning of ihe anticodon near Trp&’ at the extreme 
periphery of the molecule is determined by a long 01- 
helix which extends along the entire length of the D and 
anticodon stems. In a previous attempt to identify the 
hydrogen bond network between amino acid residues of 
yeast methionyl-tRNA synthetase and the anticodon 
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triplet of the cognate tRNAMc’, we have analysed an 
a-helical region that corresponded to the E. coli methio- 
nyl-tRNA synthetase anticodon binding region (helix 
H4’ in Fig. 1). We have mutated more than 10 potential 
amino acid donors in the equivalent yeast sequence and 
found that these mutations had little effect on tRNA 
recognition (unpublished results). This result suggests 
that the determinants of the anticodon binding region 
in the yeast system are located elsewhere in the mole- 
cule. New contacts could be identified by modelling the 
interaction of the tRNA with a structural model of the 
yeast methionyl-tRNA synthetase. In particular we 
identified an asparagine residue that is directly adjacent 
to the anticodon when the tRNA is docked to the syn- 
thetase. By sequence comparison, we noted that this 
asparagine residue falls in a highly conserved amino 
acid region that is found in all methionyl-tRNA synthe- 
tases so far sequenced. Therefore we mutated this clus- 
ter of conserved residues and analysed their effect in 
tRNA aminoacylation. 
2. MATERIALS AND METHODS 
2. I. Stmins and plasmids 
The E. co/i strain JMlOl [6] was used as recipient for the various 
plasmids and M 13 phages. The E. coli strain TG 1 was used in transfor- 
mations by phosphorothioate DNA. The genotype of TG I is indicated 
by the supplier (Amersham). Plasmid pMVT was the source of isola- 
tion of MESl gene. It allows overexpression of the MESI protein in 
a recipient strain FFI (mes/,u&) that harbours a chromosomally 
altered methionyl-tRNA synthetase whose activity is undetectable in 
vitro [9]. 
2.2. Etr:_wes and reugenrs 
Restriction endonucleases, T4 DNA ligase and E. coli DNA poly- 
merase I (Klenow fragment) were purchased from Boehringer Mann- 
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Fig. I. Juxtaposition of the yeast MetRS model (catalytic core) with the phosphate backbone tRNAy”. The phosphate backbone ofthe tRNA and 
the a-carbon backbone of the protein starting from residue 192 are shown. Region A is drawn in heavy lines and represents the HIGH and the 
KMSKS regions. Arrows are pointing to the positions of the carbon CL spheres of the residues mentioned in the text. The coordinates of Sl’, H4 
and HI’ are taken from Brunie et al. [I]. 
heim (Germany). [cr-“S]dATP and “‘I-protein A were purchased from 
Amersham (UK). 
2.3. Site-directed mrctuggmesis of the MESI structurctl gene 
The Amersham mutagenesis system based on the method of Eck- 
stein et al. [IO] was used to create single base pair mutations. The 
HindIll-BumHI fragment from the MESI gene was subcloned into 
Ml3mpl9 and used as DNA template. After transformation of the 
TG 1 strain. positive clones were identified by sequencing the DNA of 
four AmpR colonies using the Sanger dideoxy method [I I]. 
The DNA (I jcg) from Ml3 phages carrying the mutated MESI 
sequences were digested by C/u1 and HirrdIII restriction enzy. -j (2 
units) and the resulting digest was ligated directly into plasmid pMVT 
that has been successively digested with TtlrIII. CkrI, Hirrdlll (partial 
digest) and dephospho:ylated. We transformed the FFl recipient with 
the ligation mixture and selected colonies with the Ura3’ phenotype 
in the presence of methionine ( lOO~g/ml). Positive clones were coun- 
tcr-sclccted for :he Met- phenotype. Both activities, the ATP-PPi 
exchange and the tRNA aminoacylation were measured for one Met* 
colony and each Met- colony. The complete sequence of the rccon- 
strutted gene was verified. We did not find additional mutations to 
those introduced by site-directed mutagenesis. 
tructs 
Cytoplesmic methionyl-tRNA synthetase was tested in crude cx- 
tracts from exponentially growingcells, obtained by mechanical break- 
age using glass beads. Aminoacylation reactions were carried out at 
25°C under the following conditions: I44 mM Tris-HCI, pH 7.8: 5 
mM dithiothreitol; 2 mM ATP: IO mM MgCII; 0.1 mM [‘“Clmc- 
thionine (51 &Yi/flmol); 6 mg/ml yeast tRNA (the fraction of tRNA”” 
is 2%): and 5 mg/ml bovine serum albumin. At various time intervals 
40 ~1 aliquots from a 200 ~1 reaction mixture were spotted onto 
Whatman paper disks and quenched by 5% trichloroacetic acid. Ra- 
dioactivity was counted in a toluene-based scintillant. The ATP-pyro- 
phosphate exchange assays were done at 25°C using: 144 mM Tris- 
HCI. pH 7.8: 2 mM ATP: 2 mM r’P]PPi (0.35 /rCilpmol): 5 mM 
mcthioninr: !O mM potassium fluoride (an inhibitor of cndogenous 
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pyrophosphatase); 0. I mM phenylmethanesulphonylfluoride, and 
various amounts of crude enzyme. Labeled ATP was adsorbed onto 
charcoal. washed with water and the radioactivity was monitored by 
scintillation counting as above. One unit of activity corresponded to 
I nmol of [“Clntethionine incorporated into tRNA per min or 1 nmol 
of [Z’Plphosphate incorporated into A-I-P per min. The specific amount 
of methionyl-tRNA synthetase in the protein sample was estimated by 
Western blotting. Protein samples were run on 10% polyacrylamide 
gels in the presence of 0.1% sodium dodecylsulphate. Conditions for 
the transfer of proteins to nitrocellulose membranes were as described 
in Schleicher aud Schucll manual No2. The protein band correspond- 
ing to methionyl-tRNA synthetase was detected using DEAE-Se- 
phadex-purified antibodies (100 jrg) and “‘I-protein A (0.7 mCi at 50 
mCi/mg). 
3. RESULTS AND DISCUSSION 
3.1. Seqr4ertce itotnology between wriorts ntethion_vl- 
tRNA syntlretnses 
The overall homology between methionyl-tRNA 
synthetases from various sources [12-141 beyond the 
last p strand of the Rossmann fold is low (20% identi- 
tics) compared to that of the nucleotide binding fold 
(40%). However. small regions of conserved amino acid 
residues could be identified (Fig. 2). One of these is the 
GNLV-R consensus sequence that is found in all me- 
thionyl-tRNAsynthetases so far sequenced. A spectrum 
of semi-conservative amino acid replacements was 
sought for residues Asnlxa and ArgsX” of the yeast cyto- 
plasmic enzyme. At position 584, we have analysed the 
steric effect of a methy!ene group and a negative charge 
on the asparagine side chain by producing the mutants 
RsnSX4Gln and Asr?*‘Asp. To distinguish whether the 
side chain of arginine 588 makes a hydrogen or an ionic 
bond with the tRNA we have tested the replacements 
Volume 289. numbe 2 FEBS LETTERS September 1991 
lscmrsm.Frg 
Ztthmrs.Frg 
Jecmrs.Frg 
4scmrs.Frg 
Co"sensus 
lscmrsm.Frg 
2tthmrs.Frg 
3ecmrs.Frg 
4scmrs.Frg 
Co"se"sus 
lscmrsm.Frg 
Ztthmrs.Frg 
3ecmrs.Frg 
4scmrs.Erg 
Consensus 
pLprqivVhG hwlc.NGmKM SKSlGnvVdp idTaryYga0 ivRWFlLens kleeD ..gdf qeaklyetre 1LvskwGNLI "Rccgskfni era.Vmkfsd 
pMyrhLnVgG FllgpdGrKM SK:lGnvVdp fallekYgrD alRYtlLrei pygqDt.pvs eEaLrtRyea DLaddiGNLV oRtramlfrf .aeGrIce~va 
rkpsnL%hC Yvtv.NGaKM SKSrGtfIka stwl"hFdaD slRYYytak1 ssriDdidln 1EdFvqRv"a DivnkvvNLa iRnagfi"kr fdGvles:el 
tMlhhLntte YiqyeNG.Kf SKSrGvgVfg nnaqdsgisp SvWRYyLasv rpessdshfs WDdFvaRnns ELlanlGNFV "Rlikfvnak ynGvVpkfdp 
-M-_-L-"-G Y-e_-NG_Ky SKS_G-V- ..-----Y--D --RYY-L-w ____D_____ -B-F--R_-_ DL_---GNLV -R-----w-w _-G-V-__-- 
<rnw Be z.s=, < S4> <I HeV> C-Bf-> <######Y I# Hl' Y#t#C###*> <.sl'> 
kanfqFqeif qnepivseri e"iAklLnks qevFDekiAi sqypqllrhv wsiindaNtL Vqns.kPWer eldqqDn... 
geelaeg... . . . . . . . . . . tglAgrLrp1 vreLkFhvA1 ea....... a MayvkalNrY I"Ek.kPWel fkkepEea.. 
adpqlyktf. . . . . . . . . . . tdaAevigea wesrEFgkAv re....... i MaladlaNrY VdEq.aPWvv akqegrdadl 
kkvs"Yd... . . . . . ..glv kdineiLsny vkeMELgher rglei.... a Hslsargh'qF lqEnkld"t1 fsqspEks.. 
_____Y____ __________ -_-A--L_-_ ____EF__A_ __________ M------N-Y V-E--wPW-- _-_--E-b__ 
~t#lt#Ylt%U H2' #I############%*> <B###t###Y##t H3' I)####142 <I H4't> 
. . Iiflamet SRIlSilcqS 
rAVlyevveg 1RIaSillcP 
qAIcsmyi"1 fRVlmtylk? 
dAVvavglni iyavSsiitP 
~A~~~~~~~_ Ri_S____P 
< H5' > <I# HO' #1> 
iiP.sLsqsf ldr. idvske krtinyarlg sdktygkqsn kkgreVpLkK Ipfzlqeeqt "n,rs 575 
aX?dkMaElr saLgLkeevr l..Eeaerwg Laeprpipee a...pVlFpK kEakveakpk eeaw 513 
vLP.kLtEra eaF.Lntelt w..Dgiqq.p Llqhkvnpfk aly"eIcLYrq VEalveaske evka 552 
yMP.eigEki nkM.Lnspal kidDrfhlai Leghninkae ylfqeIdekK IDewrakygg qqv 751 
_MP__L_S_- ____L__-_- --_D______ L-w--w-w-- -----w---K IE _______ ___ 
<tfl H7' +I#> <##I HE' ilYU#> 
412 
377 
412 
606 
513 
454 
493 
690 
Fig. 2. Sequence alignment of the C-terminal region of various methionyl-tRNA synthetascs. The alignment is shown starting from the signature 
sequence KMSKS. The last /I strand of the Rossman fold is designated asp E according to the nomenclature adopted by Brunie et al. [I]. The 
abbreviations used are: yeast cytoplasmic enzyme (scmrs): yeast mitochondrial enzyme (scmrsm); E. co/i enzyme (ecmrs), and Tllcnnrts rhermophihrs 
enzyme (tthmrs). Numbering is from the N-terminus. The secondary structure assignments are taken from the coordinates of the resolved structure 
of the E. co/i enzyme (I). Helical regions are represented by (###) and a strands by (===). 
of Arg into glutamine and lysine. To test the importance 
of aromatic hydrophobic interactions we have changed 
PheS8’ into alanine. 
3.2. Rationale for the selection of mutant enzymes and 
measurement of the enzyme activities 
Because it was very difficult to obtain mutated DNA 
by the phosphorothioate method using the phagemid 
pMVT (containing the entire MESl gene), we perfor- 
med the mutagenesis in the MESl HindHI-BnmHI 
fragment that covers most of the adenylate binding do- 
main and the entire C-terminal helical domain. The 
ntesl mutants were reconstructed directly from a liga- 
tion mixture of two independent HindIII-ClaI digests 
of pMVT vector and Ml 3 recombinants bearing the 
mutated mesl sequences. As we used a ligation mixture 
to transform the recipient strain having a defective met- 
hionyl-tRNA synthetase, 4 possibilities can be envisa- 
ged: complementation by the pMVT vector due to in- 
complete digestion and/or dephosphorylation; comple- 
liientatiti;; by the mutant methionyl-tRNA synthetase 
whose in vivo aminoacylation level is high enough to 
sustain growth, failure of complementation due to size 
trimming of the 5’ end overhangs or lig:ition of concate- 
mers, or finally, failure of complementation due to non 
functional methionyl-tRNA synthetase mutants. The 
latter possibility can be distinguished from al! the other 
ones by determining the methionine phenotype and 
measuring the enzyme activi:i:s of the corresponding 
colonies. Phenotypically, they should be Met- and the 
mutant protein should display impaired ATP-PPi ex- 
change activity but hampered tRNA aminoacylation if 
the mutation specifically affects the tRNA-binding or 
the transfer step of the activated amino acid. Mutants 
with only partially altered tRNAMc’ aminoacylation ac- 
tivity give rise to colonies with the Met’ phenotype. 
These mutants will be distinguished from wild type en- 
zyme on the basis of the activity measurements. The 
strategy that led to the isolation of the desired mutants 
involved the following steps: (i) transformation of the 
recipient in the presence of methionine; (ii) check of the 
methionine phenotype of the Ura3’ transformants, and 
(iii) measurements of both activities in a Met* and a 
Met- colony. The results are shown in Table I. Methio- 
nyl-tRNA synthetase mutants could be isolated from 
Met- colonies for NS84Q, N584D, N584A, R588Q and 
R588K. Mutant F585A was not obtained by this genetic 
selection procedure. Our analysis did also select for sec- 
ond site revertants of the mesl locus. These clones grew 
well in the absence of methionine but showed little 
ATP-PPi exchange activity and tRNA aminoacylation 
(20 times less than the overproduced ATP-PPi ex- 
change activity) but were not further analysed. In order 
to prove that the cloned mesl mutants express a full- 
length protein we performed a SDS-polyacrylamide gel- 
electrophoresis. Fig. 3 shows that this is indeed the case 
for all mutants analyzed and we could estimate the spe- 
cific level of each mutant by immuno-blot analysis using 
polyclonal methionyl-tRNA synthetase antibodies. The 
specific activity of mutants N584D and R588Q in the 
crude extracts is 0.5-1.5% of that of the wild type and 
undetectable for mutants R588K, N584Q and N584A 
(Table I). These effects are spectacular considering the 
Table I 
Measurement of the specific activity of wild type and methionyl-tRNA 
synthetase mutants 
MetRS In vivo Relative specific activity (%) 
complementation -~ 
ATP/PPi Aminoacylation 
exchange 
wild type + 100 100 
N584D 60 0.5-1.5 
N584Q - 65 0.3 
R588A - 65 0 
R588K - 50 0.3 
R588Q _ 75 0.5-1.5 
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Fig. 3. SDS-polyacrylamide gel analysis of yeast methionyl-tRNA synthetase (MetRS) mutants. Crude protein extracts from mutants (30 pg) and 
wild type enzyme (30 and 60 fig) were separated on a 10% SDS-polyacrylamide gel. (A) 0.5 pug of purified MetRS; (B) N584A; (C) N584D; (D) 
N584Q: (E) R588A; (F) R588K; (G) R588Q; (H) protein marker: (I) recipient strain FFI; (J) and (K) 60 and 3Opg of wild type MetRS. The arrow 
indicates the position of the native MetRS. 
fact that in most cases semi-conservative amino acid 
substitutions were made. All these residues belong to 
the end of an cl-helix that is directly adjacent to the 
CAU anticodon of the tRNA according to our docking 
csperiments and may, therefore, represent residues that 
are implicated in tRNA binding or in the catalytic step. 
To clarify this problem. measurement of K,,, and k,,, 
parameters of the purified proteins will be necessary. 
We have also tested tb.e potential of the respective yeast 
mutants to aminoacylate tRNAMc’ transcripts with alte- 
red anticodon specificities (GAC, CCU, UAU and 
CAG). No mis-aminoacylation could be measured in 
vitro with the protein crude extracts previously purified 
by DEAE-cellulose chromatography. This result corro- 
borates the absence of lethality noted when the corre- 
sponding yeast transformants were grown in the pres- 
ence of methionine. 
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